Frontiers in Pharmacology
Scope & Guideline
Fostering collaboration and innovation in pharmaceutical sciences.
Introduction
Aims and Scopes
- Pharmacological Mechanisms and Drug Action:
The journal emphasizes research that elucidates the mechanisms of drug action at molecular, cellular, and systemic levels, contributing to the understanding of how drugs interact with biological systems. - Clinical Pharmacology and Therapeutics:
Publications often focus on the clinical application of pharmacological principles, including studies on drug efficacy, safety, and the pharmacokinetics and pharmacodynamics of various therapeutic agents. - Natural Products and Traditional Medicine:
There is a strong interest in exploring natural compounds and traditional herbal medicines, investigating their pharmacological effects, mechanisms of action, and potential therapeutic applications. - Pharmacogenomics and Personalized Medicine:
Research on genetic variations affecting drug metabolism and response is a significant area, promoting the development of personalized medicine approaches to optimize drug therapies. - Drug Safety and Pharmacovigilance:
The journal covers studies related to drug safety, adverse effects, and pharmacovigilance, highlighting the importance of monitoring and evaluating drug-related outcomes in clinical settings. - Innovative Drug Delivery Systems:
Research on novel drug delivery technologies, including nanoparticles and other advanced formulations, is also featured, aiming to enhance drug efficacy and reduce side effects.
Trending and Emerging
- Integrated Omics Approaches:
There is a significant rise in studies employing integrated omics methodologies (genomics, proteomics, metabolomics) to understand drug mechanisms and disease pathology, reflecting a trend towards holistic research perspectives. - Targeting the Gut Microbiome:
Research focusing on the gut microbiome's role in drug metabolism, efficacy, and disease treatment is gaining traction, highlighting its importance in personalized medicine and therapeutic outcomes. - Emerging Therapeutics and Drug Repurposing:
The journal is increasingly publishing articles on the repurposing of existing drugs for new therapeutic uses, emphasizing the potential of known compounds in treating various diseases. - Nanotechnology in Drug Delivery:
The application of nanotechnology for drug delivery systems is a rapidly growing area, with numerous studies investigating how nanoparticles can enhance the efficacy and safety of therapeutic agents. - Pharmacogenomics and Precision Medicine:
The focus on pharmacogenomics is expanding, with more research dedicated to understanding genetic influences on drug response, which is crucial for developing precision medicine strategies. - Natural Products as Therapeutic Agents:
A resurgence in interest for natural products, including herbal medicines and their bioactive components, is evident, particularly in their roles as potential candidates for innovative therapies.
Declining or Waning
- Conventional Pharmacological Approaches:
There has been a noticeable shift from traditional pharmacological studies towards more integrative and innovative methodologies, including systems biology and multi-omics approaches, reflecting a decline in purely conventional pharmacology research. - Single-Agent Drug Studies:
Research focusing solely on the effects of single-agent drugs is becoming less common, as there is a growing preference for studies that explore combination therapies and polypharmacology to address complex diseases. - Basic Pharmacology without Clinical Relevance:
Papers that do not bridge basic pharmacology with clinical applications are less frequently accepted, indicating a trend towards research that has direct implications for therapeutic practices. - Static Drug Interaction Studies:
The field is moving away from static studies of drug interactions to more dynamic models that incorporate patient-specific factors, highlighting a decline in traditional drug interaction research.
Similar Journals
PLANTA MEDICA
Harnessing the Potential of PhytochemicalsPLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
Empowering healthcare through cutting-edge pharmacological studies.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany, is a vital scholarly platform dedicated to advancing the field of pharmacology through rigorous research and innovative therapeutic strategies. Established in 1994, this journal has maintained its relevance in the evolving landscape of clinical pharmacology, achieving a Q3 rank in both general and medical pharmacology categories as of 2023. With an ISSN of 0946-1965, it is positioned as an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of drug therapy and pharmacological applications. Though it currently does not offer open access, its comprehensive scope covers a wide array of topics within pharmacology, promising to contribute significantly to scientific discussions and knowledge dissemination from 1994 to 2024. Whether you are looking for the latest studies or historical insights, the journal remains a fixture for anyone invested in the pharmacological sciences.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Innovating Therapeutic Strategies for a Healthier TomorrowThe JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.
Research in Pharmaceutical Sciences
Connecting Researchers to Shape the Future of MedicineResearch in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.
JOURNAL OF CLINICAL PHARMACOLOGY
Enhancing Therapeutic Strategies through Rigorous ResearchWelcome to the Journal of Clinical Pharmacology, an esteemed publication in the field of pharmacology and medical pharmacology, published by Wiley. Since its inception in 1973, this journal has been at the forefront of disseminating innovative research findings and comprehensive reviews that enhance our understanding of drug therapies and their clinical applications. With an impact factor that reflects its strong reputation and a Scopus ranking placing it in the 64th percentile among 272 journals in medical pharmacology, the journal stands as a critical resource for researchers, healthcare professionals, and students alike. Although currently not an Open Access journal, it provides invaluable insights into therapeutic drug use and safety, the pharmacokinetics of drugs, and the development of new therapeutic strategies. The journal's commitment to advancing the field through high-quality, peer-reviewed articles ensures it remains a vital asset in the continuously evolving landscape of clinical pharmacology.
Chinese Journal of Natural Medicines
Championing Research in Alternative HealingThe Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.
Iranian Journal of Pharmaceutical Research
Championing excellence in pharmacological research and discovery.Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.
ANTI-CANCER DRUGS
Unveiling Breakthroughs in Cancer TherapeuticsANTI-CANCER DRUGS is a leading journal in the domain of cancer research and pharmacology, published by Lippincott Williams & Wilkins. With its inception dating back to 1990 and ongoing publication through 2024, this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements and discoveries in cancer therapeutics. Although classified in the Q3 quartile across relevant categories such as Cancer Research and Oncology, its growing impact is evidenced by its competitive Scopus rankings, positioned within the 30th to 52nd percentiles across various disciplines. The journal remains committed to promoting innovative research that can translate into effective anti-cancer strategies, providing valuable insights into drug development and applications. While it does not currently offer open access, the journal continues to attract a sophisticated readership, making it an essential platform for disseminating significant findings in the ever-evolving field of oncology.
Pharmaceutical Sciences
Advancing pharmaceutical knowledge for a healthier future.Pharmaceutical Sciences, an esteemed journal published by Tabriz University of Medical Sciences, Faculty of Pharmacy, serves as a crucial platform for the dissemination of pioneering research in the fields of pharmaceutical science, pharmacology, and toxicology. With an impact factor reflective of its substantial contribution to the scientific community, this open access journal has been accessible since 2012, ensuring that researchers, professionals, and students worldwide can engage with its rich content. Located in Iran, it has continually evolved, covering research from 2009 to 2024, and boasts impressive rankings in multiple Scopus categories, including Q3 in Pharmaceutical Science and Q2 in Pharmacology, Toxicology and Pharmaceutics. By bridging gaps between scientific inquiry and practical applications, Pharmaceutical Sciences is dedicated to advancing pharmaceutical knowledge and promoting innovative practices that address significant health challenges.
DRUG DEVELOPMENT RESEARCH
Advancing pharmaceutical innovation through rigorous research.DRUG DEVELOPMENT RESEARCH is a premier interdisciplinary journal published by Wiley, focusing on the latest advancements in drug discovery, pharmacology, and toxicology. With an ISSN of 0272-4391 and an E-ISSN of 1098-2299, this esteemed publication has been a cornerstone in the field since its inception in 1981 and continues to provide cutting-edge research until 2024. Its rigorous peer-review process and strategic placement in Q2 of the Drug Discovery category, as well as ranking #60 out of 157 in Scopus, underscore the journal's relevance and influence, boasting a respectable 62nd percentile ranking. While the journal does not currently offer open access, it remains a vital resource for researchers, professionals, and students seeking to expand their knowledge on the processes of drug development, identifying new therapeutic targets, and assessing the efficacy and safety of novel compounds. Situated in Hoboken, NJ, this journal stands at the forefront of pharmaceutical innovation, making significant contributions to the advancement of medical science.